Mood stabilizers, glycogen synthase kinase-3β and cell survival
Open Access
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 7 (S1) , S35-S45
- https://doi.org/10.1038/sj.mp.4001017
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for MagnesiumBiochemical and Biophysical Research Communications, 2001
- A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐cateninFEBS Letters, 1999
- Lithium protects cultured neurons against β‐amyloid‐induced neurodegenerationFEBS Letters, 1999
- Insulin Transiently Increases Tau PhosphorylationJournal of Neurochemistry, 1999
- Expressions of CCAAT/Enhancer-binding Proteins β and δ and Their Activities Are Intensified by cAMP Signaling as Well as Ca2+/Calmodulin Kinases Activation in Hippocampal NeuronsPublished by Elsevier ,1998
- Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neuronsFEBS Letters, 1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Lithium Delays the Radiation-induced Apoptotic Process in External Granule Cells of Mouse Cerebellum.Journal of Radiation Research, 1995
- Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tauFEBS Letters, 1992
- Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinaseNeuroscience Letters, 1992